Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT04419558 · TERMINATED
Trial details
- NCT number
- NCT04419558
- Sponsor
- Kyntra Bio
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-09-04
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.